{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:36:36Z","timestamp":1787589396284,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004883","name":"Shahrekord University","doi-asserted-by":"publisher","award":["96GRD1M32855"],"award-info":[{"award-number":["96GRD1M32855"]}],"id":[{"id":"10.13039\/501100004883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00404-019-05107-x","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T15:55:26Z","timestamp":1551282926000},"page":"1453-1458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis"],"prefix":"10.1007","volume":"299","author":[{"given":"Seyed Omar","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-7645","authenticated-orcid":false,"given":"Somayeh","family":"Reiisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"5107_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"5107_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jnci\/dju410","volume":"107","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gr\u00f6nberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst 107:410","journal-title":"J Natl Cancer Inst"},{"key":"5107_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Obstet Gynecol 124:1\u20135","journal-title":"Int J Obstet Gynecol"},{"key":"5107_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C et al (2011) Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305:2295\u20132303","journal-title":"JAMA"},{"key":"5107_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/249393","volume":"2014","author":"Y Kinose","year":"2014","unstructured":"Kinose Y, Sawada K, Nakamura K, Kimura T (2014) The role of microRNAs in ovarian cancer. BioMed Res Int 2014:1\u201311","journal-title":"BioMed Res Int"},{"key":"5107_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih I-H, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787\u2013798","journal-title":"Cell"},{"key":"5107_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","volume":"285","author":"K Ruan","year":"2009","unstructured":"Ruan K, Fang X, Ouyang G (2009) MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285:116\u2013126","journal-title":"Cancer Lett"},{"key":"5107_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12985-015-0288-2","volume":"12","author":"M Xun","year":"2015","unstructured":"Xun M, Ma C-F, Du Q-L, Ji Y-H, Xu J-R (2015) Differential expression of miRNAs in enterovirus 71-infected cells. Virol J 12:56","journal-title":"Virol J"},{"key":"5107_CR9","doi-asserted-by":"publisher","first-page":"e0160780","DOI":"10.1371\/journal.pone.0160780","volume":"11","author":"X Chen","year":"2016","unstructured":"Chen X, Zhong S-L, Lu P, Wang D-D, Zhou S-Y, Yang S-J et al (2016) miR-4443 participates in the malignancy of breast cancer. PLoS ONE 11:e0160780","journal-title":"PLoS ONE"},{"key":"5107_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12885-016-2938-1","volume":"16","author":"A Meerson","year":"2016","unstructured":"Meerson A, Yehuda H (2016) Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells. BMC cancer 16:882","journal-title":"BMC cancer"},{"key":"5107_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3727\/096504016X14831120463349","volume":"25","author":"Z Jiang","year":"2017","unstructured":"Jiang Z, Zhang Y, Cao R, Li L, Zhong K, Chen Q et al (2017) MiR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5. Oncol Res 25:1081\u20131087","journal-title":"Oncol Res"},{"key":"5107_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jgo.2016.07.008","volume":"7","author":"WP Tew","year":"2016","unstructured":"Tew WP (2016) Ovarian cancer in the older woman. J Geriatr Oncol 7:354\u2013361","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"5107_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/bjc.2016.273","volume":"115","author":"S Kommoss","year":"2016","unstructured":"Kommoss S, Gilks CB, du Bois A, Kommoss F (2016) Ovarian carcinoma diagnosis: the clinical impact of 15 years of change. Br J Cancer 115(8):993\u2013999","journal-title":"Br J Cancer"},{"key":"5107_CR14","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1158\/1078-0432.CCR-16-1391","volume":"22","author":"SJ Skates","year":"2016","unstructured":"Skates SJ (2016) EPIC early detection of ovarian cancer. Clin Cancer Res 22:4542\u20134544","journal-title":"Clin Cancer Res"},{"key":"5107_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1386","author":"AC Panda","year":"2017","unstructured":"Panda AC, Grammatikakis I, Munk R, Gorospe M, Abdelmohsen K (2017) Emerging roles and context of circular RNAs. Wiley Interdiscip Rev RNA. \n                    https:\/\/doi.org\/10.1002\/wrna.1386","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"5107_CR16","doi-asserted-by":"publisher","first-page":"15913","DOI":"10.4238\/2015.December.7.2","volume":"14","author":"H Zhang","year":"2015","unstructured":"Zhang H, Sun F, Li S (2015) Serum miR-200c expression level as a prognostic biomarker for gastric cancer. Genet Mol Res 14:15913\u201315920","journal-title":"Genet Mol Res"},{"key":"5107_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","volume":"186","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Steele R, Shrivastava S, Chakraborty S, Di Bisceglie AM, Ray RB (2016) Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma. Am J Pathol 186:242\u2013247","journal-title":"Am J Pathol"},{"key":"5107_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/sj.onc.1209762","volume":"26","author":"S Camilleri-Broet","year":"2007","unstructured":"Camilleri-Broet S, Cremer I, Marmey B, Comperat E, Viguie F, Audouin J et al (2007) TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene 26:142\u2013147","journal-title":"Oncogene"},{"key":"5107_CR19","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/sj.onc.1209289","volume":"25","author":"R Li","year":"2006","unstructured":"Li R, Wang H, Bekele B, Yin Z, Caraway N, Katz R et al (2006) Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25:2628\u20132635","journal-title":"Oncogene"},{"key":"5107_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1525-1438.2006.00749.x","volume":"17","author":"H Zheng","year":"2007","unstructured":"Zheng H, Kavanagh J, Hu W, Liao Q, Fu S (2007) Hormonal therapy in ovarian cancer. Int J Gynecol Cancer 17:325\u2013338","journal-title":"Int J Gynecol Cancer"},{"key":"5107_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1134\/S0006297916060031","volume":"81","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Tian H, Miao Y, Feng X, Li Y, Wang H et al (2016) Upregulation of p72 enhances malignant migration and invasion of glioma cells by repressing Beclin1 expression. Biochem (Mosc) 81:574\u2013582","journal-title":"Biochem (Mosc)"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05107-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T19:11:11Z","timestamp":1582744271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05107-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["5107"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05107-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest with any non-financial or financial organization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving FFPE samples were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all available or alive individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}